Cargando…
Development of an interfering peptide M1-20 with potent anti-cancer effects by targeting FOXM1
Disrupting protein–protein interactions (PPIs) has emerged as a promising strategy for cancer drug development. Interfering peptides disrupting PPIs can be rationally designed based on the structures of natural sequences mediating these interactions. Transcription factor FOXM1 overexpresses in multi...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439915/ https://www.ncbi.nlm.nih.gov/pubmed/37598210 http://dx.doi.org/10.1038/s41419-023-06056-9 |